RAC 0.63% $1.59 race oncology ltd

RAC - Charts & Price Action, page-11309

  1. 5,782 Posts.
    lightbulb Created with Sketch. 1331
    RAC is well undervalued don't even put what RAC has done since buying (bisantrene)
    With testing that has been done before RAC took over we should be around $4 mark.
    Then you have to add all that has been done from when RAC took over.
    And more importantly the timeline we have saved by testing that has been done before we even bought Zantrene® (bisantrene).
    I am still very bullish that we will get to $30 mark sometime in the next year or 2 MAX.
    bought out.
    Yes there is risk but each announcement that comes out lowers that risk.
    Can't help the world is very volatile at the moment but when that right announcement comes out market will catch up.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.